CYP21A2 and rheumatoid arthritis: CYP21A2, as well as MSH5, PPP1R18, and NEU1 have been demonstrated by previous GWASs associated with other autoimmune disorders such as RA, ankylosing spondylitis (AS), T1DM, and SLE (31–33, 43, 44).